POTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE
|
|
- Rebecca Dickerson
- 5 years ago
- Views:
Transcription
1 Br.J. Anaesth. (987), 9, 0-06 POTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE S. J. KEENS, J. M. HUNTER, S. L. SNOWDON AND J. E. UTTING Volatile anaesthetic agents are already known to potentiate many competitive neuromuscular blockers. Thus neuromuscular blockade produced by tubocurarine has been shown to be potentiated by halothane (Katz and Gissen, 967) and, to a greater extent, by enflurane (Lebowitz, Blitt and Walts, 970) and isoflurane (Miller et al., 97). Similarly, pancuronium has been shown to be potentiated by halothane (Katz, 97), enflurane (Schuh, 98) and isoflurane (Miller et al., 97). The requirement for alcuronium is also known to be decreased when volatile anaesthetic agents are used (Grimmeisen, 96), but there is no information available as to the quantitative effect of volatile agents on the block produced by this agent, despite its widespread use in the U.K. It was decided, therefore, to study the effect of three commonly-used volatile anaesthetic agents, halothane, enflurane and isoflurane, on the neuromuscular blockade produced by alcuronium, monitoring neuromuscular function by electromyography (EMG). Two approaches were used: in the first, conventional cumulative doseresponse curves were constructed; in the second, a more clinical approach was used and an attempt was made to determine the effect of the volatile agents on the degree and duration of blockade following a single dose of neuromuscular blocker. PATIENTS AND METHODS Ethical committee approval was obtained and a total of 60 patients, scheduled for general surgical S. J. KEENS,* M.B., F.F.A.R.CLS.; JENNIFER M. HUNTER, M.B., F.F-A.R.CS. ; S. L. SNOWDON, M.B., F.F.A.R.OS.; J. E. UTTING, M.B., F.F.A.R.C.S.; University Department of Anaesthesia, Royal Liverpool Hospital, Prescot Street, P.O. Box 7, Liverpool L69 BX. Accepted for Publication: July, 986. Present address, for correspondence: Anaesthetic Department, Royal Preston Hospital, Sharoe Green Lane, Preston, Lancashire PR HT. SUMMARY The potentiation of alcuronium by halothane, enflurane and isoflurane was investigated using e/ectromyography. In the first study, cumulative dose-response curves were constructed in four groups of 0 patients anaesthetized with one of the inhalation agents and nitrous oxide, or with fentanyl and droperidol {control). All three agents reduced the ED^ of alcuronium; the effect was marked with isoflurane (P < 0.00) but less so with halothane (P < 0.0) and enflurane (ns). In the second part of the investigation, designed primarily to test the duration of action of alcuronium with each agent, a single bolus dose of alcuronium 0. mg kg' was given to four similar groups (n = ). The duration of action was significantly prolonged by enflurane (P < 0.0) and isoflurane (P < 0.0), but not by halothane. The possible reasons for this are discussed. or gynaecological operations, gave consent to their inclusion in the study. Each patient was premedicated with promethazine 0 mg orally the night before operation, with or without morphine 0 mg and cyclizine 0 mg i.m. h before the expected start of surgery. In both parts of the study, the concentrations of the volatile agent(s) were measured using a "Normac" anaesthetic agent monitor (Datex Ltd), the calibration of which had been verified using a flame ionization detector and calibrated gas mixtures. End-tidal carbon dioxide concentrations were measured using a capnometer (Datex Ltd) which had been calibrated against cylinders of known composition. Sampling for both volatile agents and carbon dioxide concentrations was via a cannula inserted through the face mask angle-
2 0 BRITISH JOURNAL OF ANAESTHESIA piece and later through the catheter mount. The ECG was monitored continuously and arterial pressure was measured regularly with an oscillotonometer. Dose-response curves Four groups each of 0 patients were studied. In the first group (group ), anaesthesia was induced with fentanyl, droperidol and thiopentone; the patient then breathed nitrous oxide and oxygen (0%) via an anaesthetic face mask, ventilation being assisted if necessary to maintain the end-tidal carbon dioxide concentration between and 6%. At this stage, control EMG traces were obtained. After this had been achieved, alcuronium was given in divided doses of 0 ng kg" at intervals of min until the evoked action potential had decreased to less than 0% of control and at least four increments of alcuronium had been given. The study was then terminated, and a tracheal tube was passed. In the other three groups, induction of anaesthesia was with thiopentone alone. The patient then breathed nitrous oxide in oxygen while control EMG measurements were obtained. Immediately these had been achieved, halothane (group ), enflurane (group ) or isoflurane (group ) was added and, after an induction period of 0 min, end-tidal concentrations were kept constant (to within 0.%) at 0.7% halothane,.7% enflurane and.% isoflurane for a further 0 min, making 0 min in all. Alcuronium was then given in divided doses as described for group. Single bolus dose study In the second part of the study, 0 patients were given a single bolus dose of alcuronium 0. mg kg", after control EMG traces had been recorded in the manner described above. Tracheal intubation was performed and anaesthesia supplemented by either fentanyl and droperidol (group ), halothane (0.% end-tidal concentration; group 6), enflurane ( % end-tidal concentration; group 7) or isoflurane (0.7% end-tidal concentration; group 8). Artificial ventilation was established and the end-tidal carbon dioxide concentration was maintained throughout anaesthesia between 6%, the ventilatory rate being b.p.m. Monitoring by electromyography was continued until the first incremental dose of alcuronium was given. Neuromuscular monitoring The method of monitoring neuromuscular function by electromyography has been described previously (Calvey, 98). The skin was cleaned with acetone and the hand immobilized in a splint. ECG electrodes were placed over the ulnar nerve in the forearm for stimulation, and recording electrodes (Conn Med Stress ECG electrodes) placed over the adductor pollicis brevis and the base of the index finger on the palm of the hand. A copper earth electrode was placed between the stimulating and recording electrodes. Stimulation voltage was increased until the evoked compound muscle action potential (CMAP) reached its maximum height, after which the voltage was increased by a further % to ensure supramaximal stimulation. The positions of the recording electrodes were adjusted, if necessary, to give a biphasic CMAP trace. The stimulator was set to deliver single pulses with a width of 0. ms duration every s (0.08 Hz) in the first part of the study (groups ) as this mode of stimulation was similar to that used in other work on cumulative dose responses (Donlon, Ali and Savarese, 97). A train-of-four ( Hz) every min was used in the second part of the study, as this was more practicable for use over a prolonged period. EMG signals were amplified with an isolated biological amplifier having frequency filters set at -. KHz and recorded on u.v. light-sensitive paper from the trace displayed on the oscilloscope of a Medelec MS6 EMG machine. Method of analysis In every patient, the height of each action potential was measured and expressed as a percentage of the height of the control. These values were then plotted on a graph against time. In the first part of the study, the degree of depression of the action potential caused by each increment of neuromuscular blocker was calculated and plotted on log-probit axes (fig. ). The ED 0 values were read from these individual dose-response plots. Before comparing these ED M it was necessary to ensure that the lines were parallel. A straightforward mathematical slope could not be determined, since the axes were not linear, one being logarithmic, the other a probit scale. A measure of the slope of each line was, therefore, obtained from a slope function determined by a graphical method (Litchfield and
3 NEUROMUSCULAR BLOCKADE WITH ALCURONIUM 0 TABLE I. The ED W (pg kg *)for alcuronium is given for each of the four groups studied, together with the SEM. The significance level, obtained using Wilcoxon Rank Sum Test, of a comparison between group I and each of the other three groups is also noted. No significant difference (ns) was found between enflurane and fentanyl using this method Group ED., SEM Significance level. Fentanyl. Halothane. Enflurane. Isoflurane <0.0 ns < Alcuronium (pg kg' ) 00 FIG.. Log-dose-response curve. Graph drawn from the data obtained from one patient with % decrease in height of compound muscle action potential (CMAP) plotted on a probit scale against the cumulative dose of alcuronium on a logarithmic scale. Point A = ED,,; Point B = ED M ; Point C = ED M. Wilcoxon, 99). The slope function was given by the formula ED 8 /ED 60 + ED 60 /ED 6 The mean slope function of the groups did not differ significantly. The mean ED 60 values of the groups were then compared using a nonparametric test of significance: the Wilcoxon Rank Sum Test (Wilcoxon, 9). In the second part of the study, the rate of recovery from the neuromuscular blockade produced by a standard dose of alcuronium was studied. The time from the maximum depression of the height of the first of the train-of-four action potentials to the point at which the height of the action potential had recovered by one-tenth of that maximum depression was measured in a manner similar to that used by Miller and co-workers (97). For example, if the height of the control CMAP was 0 mm and this was depressed to mm (90 % depression), the time taken to recover by a height of 0 /0 =.6 mm (i.e. to 7.6 mm) was taken as an indication of the duration of the effect of alcuronium on the CMAP. RESULTS Cumulative dose-response curves The results of the cumulative dose-response study are shown in table I. The apparent ED M of alcuronium with each of the volatile agents was less than it was in the control group. This reduction was greatest with isoflurane (P < 0.00). A smaller, although still significant, decrease was found in the halothane group (P < 0.0). The mean ED 60 in the enflurane group (9.6 ug kg" ) was not statistically different from the mean ED 60 in the fentanyl group (06.8 ug kg" ), even though this difference was greater than that for the halothane group (mean EDJO 96. ug kg" ). This apparent anomaly is explained by greater variability within the enflurane group. Single bolus dose study The minimum height of the CMAP after a standard 00-ug kg" bolus dose of alcuronium was very variable in those patients given an inhalation agent (table II), and ranged from a maximum depression of % of control (patient of the enflurane group) to a minimum depression of % (patient of the isoflurane group). In contrast, there was much less variation between patients in the fentanyl group (range from 6 % to 7 % of control). The time from injection of the neuromuscular blocker to the maximum depression also varied greatly and this variation was especially marked in the enflurane group where it ranged from 8 to min. As can be seen (table II), the variability in the fentanyl group was much less (from 8 to 6 min). The mean time taken for recovery to one-tenth of the maximum degree of depression was greatest in the isoflurane group (mean.6 min) compared with the fentanyl group (mean of.6 min); this difference reached a significance level of 0.0. The increase in mean recovery time in the enflurane group (mean of 0.8 min) was less than that in the isoflurane group but, because of less
4 0 BRITISH JOURNAL OF ANAESTHESIA TABLE II. The smallest height of the CMAP as a percentage of control in each of the patients who received a tingle bolus of alcuronium 0. mg kg' is given, together with the mean value obtained in each group. Also recorded is the time from injection of the alcuronium to the maximum depression of the CMAP in each patient and the time to recovery to /0 of the maximum depression. Statistical significance using the Wilcoxon Rank Sum Test between the mean value for each group and the mean value for the fentanyl group is also given : *0.0S;**0.0;ns>0.0 Group Patient No. Minimum height of CMAP (% of control) Time from injection of relaxant to maximum depression ofcmap(min) Time to recovery to /0 of the maximum depression (min) : Fentanyl : Halothane (ns) (ns) (ns) 7: Enflurane (ns) (ns) ** 8: Isoflurane (ns) 9.8 (ns).6* variability within the group, reached a significance level of 0.0. There was no prolongation of the recovery time in the group of patients anaesthetized with halothane (.8 min) compared with the fentanyl group (.6 min). DISCUSSION The results of the cumulative dose response study show a greater effect on the compound muscle action potential by incremental doses of alcuronium when anaesthesia is supplemented by volatile anaesthetic agents. Surprisingly, the smallest effect was in the group anaesthetized with enflurane, which is usually considered to be the most potent agent for potentiating the competitive neuromuscular blockers (Schuh, 98). There is a spectrum of potentiation of the competitive neuromuscular blockers, with less potentiation of the shorter-acting drugs such as atracurium (Rupp, McChristian and Miller, 98) and vecuronium (Rupp, Miller and Gencarelli, 98) than the longer acting neuromuscular blockers such as pancuronium and tubocurarine. Alcuronium is a synthetic derivative of tubocurarine, which itself is markedly potentiated by enflurane (Schuh, 98), and it might be expected that alcuronium would be similarly potentiated. The most obvious possibility for failing to find a marked potentiation by this agent in the dose-response study whilst at the same time finding that the volatile agent markedly prolonged the duration of action of the neuromuscular blocker is that ethical constraints imposed on the investigators meant that time for full equilibration might not have been allowed and, in particular, equilibration at the neuromuscular junction may not have been complete. This factor may well have been more important with enflurane than with the
5 NEUROMUSCULAR BLOCKADE WITH ALCURONIUM 0 other volatile agents, although it must be said that it is surprising, if this be the case, that the dose-response curves of the enflurane group were closely parallel to the others. It has been found that potentiation of neuromuscular blockade by enfiurane increases linearly with duration of exposure for at least - h (Stanski et al., 980). A slow linear increase might not greatly affect the slope of the dose response curve as the time taken to perform this study was relatively short, but it might be expected that the rate of recovery would be substantially affected by a progressive increase in potentiation of alcuronium if this were measured over a relatively long period of time (the time from injection of neuromuscular blocker until recovery to one-tenth of the maximum depression in the enflurane group was 7. min). In fact, there was marked prolongation of the effect of alcuronium by both isoflurane and enflurane, despite only moderate reduction in the ED S0. This illustrates a crucial limitation of the value of dose-response curves in determining the potentiation of neuromuscular blockers by volatile agents; with enflurane, at least, different dose-response curves might be obtained for up to h, depending on the duration of exposure to the agent. There are, however, other problems. The onset time of block by competitive neuromuscular blockers is longer under enflurane anaesthesia than under halothane (Rupp, Miller and Gencarelli, 98) and, as the increments in the present study were given at regular -min intervals, the maximum depression of the CMAP may not have been reached in the enflurane group before the next increment of alcuronium was given although inspection of the traces suggested that this was not so. The cumulative dose technique is a satisfactory way of comparing different neuromuscular blockers only if their duration of action is long compared with the time taken to perform the cumulative dose-response procedure (Donlon, Ali and Savarese, 97; Donlon et al., 980). It is less satisfactory with shorter acting agents of which the duration of action is short relative to the time for the cumulative dose procedure (Ording et al., 98). In the latter case, erroneous results may be produced because the first dose of the relaxant has worn off appreciably before the last dose has its maximum effect. Alcuronium, however, is sufficiently long-acting to justify the use of the cumulative dose technique. Most studies of potentiation by volatile agents have used mechanical twitch response, although electromyography of the adductor pollicis has been used to show that halothane increased both the degree and duration of neuromuscular blockade caused by atracurium (Stirt et al., 98). By using electromyography, any direct depressant effect of enflurane on muscular contractility might not be manifest. If the potentiation caused by enfiurane was, therefore, largely the result of a direct depressant effect on muscular contraction, studies measuring the effects on muscle cell depolarization (i.e. electromyography) might demonstrate less effect with enflurane. The fundamental finding of this study is that the action of alcuronium is prolonged markedly both by isoflurane and enflurane. Thus, although the "intubating" dose of alcuronium when using enflurane or isoflurane will be approximately the same as when using a neurolept technique or halothane, the duration of effect of alcuronium will be very much longer in those receiving these agents. Thus problems could arise if incremental doses are given "by the clock" when using these anaesthetic supplements although the difficulty might be less with halothane or with a neurolept technique. Relative overdose may lead to difficulty in antagonism of blockade at the end of prolonged surgery, as has been shown when enflurane is used in conjunction with pancuronium (Delisle and Bevan, 98), and it is suggested that some form of monitoring of neuromuscular function should be undertaken when using myoneural blocking drugs in conjunction with enflurane or isoflurane for anything other than short procedures. ACKNOWLEDGEMENTS This study was funded in part by a grant from the Mersey Regional Health Authority. REFERENCES Calvey, T. N. (98). Assessment of neuromuscular blockade by electromyography, A review. J. R. Soc. Mtd., 77, 6. Delisle, S., and Bevan, D. R. (98). Impaired neostigmine antagonism of pancuronium during enflurane anaesthesia in man. Br. J. Aruusth.,,. Donlon, J. V., Ali, H. H., and Savarese, J. J. (97). A new approach to the study of four non-depolarising muscle relaxants in man. Aneith. Analg.,, 9. Savarese, J. J., Ah, H. H., and Teplik, R. S. (980). Human dose-response curves for neuromuscular blocking drugs a comparison of two methods of construction and analysis. Anetthesiology,, 6. Grimmeisen, H. (96). Diallyl-nor-toxiferin. Erfahrungen mit einem neuartigen Muskelrelaxans. Anaesihtsisi,, 8.
6 06 BRITISH JOURNAL OF ANAESTHESIA Katz, R. L. (97). Modification of the action of pancuronium by succinylcholine and halothane. Anesthesiology,, 60. Gissen, A. J. (967). Neuromuscular and elcctromyographic effects of halothane and its interactions with d-tubocurarine in man. Anesthesiology, 8, 6. Lebowitz, M. H., Blitt, C. D., and Walts, L. F. (970). Depression of twitch response to stimulation of the ulnar nerve during ethrane anesthesia in man. Anesthesiology,,. Litchfield, F. T., and Wilcoxon, F. (99). A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther., 96, 99. Miller, R. D., Eger, E. I., Way, W. L., Stevens, W. C, and Dolan, W. M. (97). Comparative neuromuscular effects of forane and halothane alone and in combination with d-tubocurarine in mnn Anesthesiology,, 8. Way, W. L., Dolan, W. M., Stevens, W. C, and Eger, E. I. (97). The dependence of pancuronium and d- tubocurarine induced neuromuscular blockade on the alveolar concentrations of halothane. Anesthesiology, 7,7. Ording, H., Skovgaard, L. T., Engbaek, J., and Viby- Mogensen, J. (98). Dose-response curves for vecuronium during halothane and neurolept anaesthesia; Single bolus versus cumulative method. Acta Anaesthesiol. Scand., 9,. Rupp, S. M., McChristian, J. W., and Miller, R. D. (98). Atracurium neuromuscular blockade during halothane/n,o and enflurane/n t O anesthesia in humans. Anesthesiology, 6, A88. Miller, R. D., and Gencarelli, P. J. (98). Vecuronium induced neuromuscular blockade during enflurane, isoflurane and halothane anesthesia in humans. Anesthesiology, 60, 0. Schuh, F. T. (98). Differential increase in potency of neuromuscular blocking agents by enflurane and halothane. Int. J. Clin. Pharmacol. Ther. Toxicol.,, 8. Stanski, D. R., Han, J., Miller, R. D., and Sheiner, L. B. (980). Time dependent increase in sensitivity to d- tubocurarine during enflurane anesthesia in man. Anesthesiology, SI, 8. Stirt, J. A., Katz, R. L., Murray, A. L., Schehl, D. L., and Lee, C. (98). Modification of atracurium blockade by halothane and by suxamethonium. Br. J. Anaesth.,, 7S. Wilcoxon, F. (9). Individual comparisons by ranking methods. Biometrics Bulletin,, 80.
POST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS
Br. J. Anaesth. (9), 60, 3-35 POST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS S. A. RIDLEY AND D. J. HATCH Atracurium degrades rapidly and, because
More informationPOST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN
Br. J. Anaesth. (988), 6, 55-556 POST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN S. A. RIDLEY AND N. BRAUDE Monitoring of profound neuromuscular blockade may be based
More informationVECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION
Br. J. Anaesth. (1985), 57, 765-769 VECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION J. E. CALDWELL, J. M. BRAIDWOOD AND D. S. SIMPSON Although artificial ventilation can be used to avoid
More informationDETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES
British Journal of Anaesthesia 1991; 66: 469-45 DETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON, R. J. DAWSON, P.
More informationEVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY
Br. J. Anaesth. (1988), 60, 450-455 EVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY A. K. MILLS AND J. A. J. MARTYN Depolarizing neuromuscular blocking drugs such
More informationPRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN
British Journal of Anaesthesia 1990; 64: 577-581 PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN C. E. SMITH, J.
More informationPHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS
British Journal of Anaesthesia 1993; 71: 227-231 PHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS J. C. DEVLIN, A. G. HEAD-RAPSON, C. J. R. PARKER AND J. M. HUNTER SUMMARY Ten
More informationHST-151 Clinical Pharmacology in the Operating Room
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructors: Dr. Carl Rosow, Dr. David Standaert and Prof. Gary Strichartz 1 HST-151 Clinical Pharmacology in
More informationFENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA
Br. J. Anaesth. (1985), 5, 250-254 FENTANYL BY CONSTANT RATE I.V. INFUSION FOR POSTOPERATIVE ANALGESIA W. S. NIMMO AND J. G. TODD is a synthetic opioid analgesic 50 times more potent than morphine, with
More informationXiaochong Fan, Minyu Ma, Zhisong Li, Shengkai Gong, Wei Zhang, Yuanyuan Wen
Int J Clin Exp Med 2015;8(9):16369-16373 www.ijcem.com /ISSN:1940-5901/IJCEM0008198 Original Article The relationship between the target effective site concentration of rocuronium and the degree of recovery
More informationNITROUS OXIDE ELIMINATION AND DIFFUSION HYPOXIA DURING NORMO- AND HYPOVENTILATION
British Journal of Anaesthesia 1993; 71: 189-193 NITROUS OXIDE ELIMINATION AND DIFFUSION HYPOXIA DURING NORMO- AND HYPOVENTILATION S. EINARSSON, O. STENQVIST, A. BENGTSSON, E. HOULTZ AND J. P. BENGTSON
More informationCOMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM
COMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM *Lata D. Shetty Department of Anaesthesiology, Khaja Banda Nawaz Institute of Medical Sciences Gulbarga, Karnataka, India
More information*Author for Correspondence
COMPARATIVE EVALUATION OF ONSET TIME INTUBATING CONDITION JUDGED BY CLINICAL CRITERIA AND HAEMODYNAMIC RESPONSE AFTER THE INTUBATING DOSE OF ROCURONIUM AND VECURONIUM *Namita Gupta 1, Mamta Sharma 2, Pusplata
More informationPRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING
Br. J. Anaesth. (1989), 63, 76-80 PRODUCTION OF LAUDANOSINE FOLLOWING INFUSION OF ATRACURIUM IN MAN AND ITS EFFECTS ON AWAKENING G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON AND D. P. CRANKSHAW The continuous
More informationMonitoring of neuromuscular block Conor D McGrath BSc(Hons) MB ChB FRCA
Conor D McGrath BSc(Hons) MB ChB FRCA Jennifer M Hunter MB ChB PHD FRCA There is increasing evidence that residual neuromuscular block is common, and also that it may adversely affect patient outcome.
More informationThe effect of desflurane on rocuronium onset, clinical duration and maintenance requirements
(Acta Anaesth. Belg., 2006, 57, 349-353) The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements R. G. STOUT (*), T. J. GAN (**), P. S. A. GLASS (***), D. G. SILVERMAN
More informationreceptors determines clinical symptoms of the patients and modulates the sensitivity to nondepolarizing neuromuscular
346 Anesthesiology 2000; 93:346 50 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Preanesthetic Train-of-four Fade Predicts the Atracurium Requirement of Myasthenia
More informationDYSTROPHIA MYOTONICA AND ATRACURIUM
Br.J. Anaesth. (1985), 57, 1131-1135 DYSTROPHIA MYOTONICA AND ATRACURIUM A Case Report P. NIGHTINGALE, T. E. J. HEALY AND K. McGUINNESS Dystrophia myotonica is the most serious and the most common of the
More informationINTRAOCULAR PRESSURE CHANGES DURING RAPID SEQUENCE INDUCTION OF ANAESTHESIA: COMPARISON OF PROPOFOL AND THIOPENTONE IN COMBINATION WITH VECURONIUM
Br. J. Anaesth. (1988), 60, 379-383 INTRAOCULAR PRESSURE CHANGES DURING RAPID SEQUENCE INDUCTION OF ANAESTHESIA: COMPARISON OF PROPOFOL AND THIOPENTONE IN COMBINATION WITH VECURONIUM R. K. MIRAKHUR, W.
More informationA defasciculating dose of d-tubocurarine causes resistance to succinylcholine
538 A defasciculating dose of d-tubocurarine causes resistance to succinylcholine James B. Eisenkraft MO MRCP FFARCS, Melinda L. Mingus io, Andrew Herlich DMI~ MD, W. Jeffrey Book MO FRCPC, Aaron F. Kopman
More informationBritish Journal ofanaesthesia 85 (2): (2000)
British Journal ofanaesthesia 85 (2): 251-5 (2000) Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal
More informationMaterials and Methods
Anesthesiology 2001; 95:96 101 2001 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. The Corrugator Supercilii, Not the Orbicularis Oculi, Reflects Rocuronium Neuromuscular
More informationINTUBATING CONDITIONS AND INJECTION PAIN
INTUBATING CONDITIONS AND INJECTION PAIN - Cisatracurium or Rocuronium versus Rocuronium-Cisatracurium Combination - AHED ZEIDAN *, NAZIH NAHLE *, HILAL MAALIKI ** AND ANIS BARAKA *** Summary The present
More informationEvaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric patients
Original Article Evaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric Abdul Kuddus Khan 1*, MM Abdul Wadud 2, Azizul Gafur 3, Rafayetullah
More informationThe Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine
The Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine Mohammad I. El-Orbany, MD, Ninos J. Joseph, BS, M. Ramez Salem, MD, and Arthur J. Klowden, MD Department
More informationEFFECTS OF NITROUS OXIDE ON AUDITORY CORTICAL EVOKED POTENTIALS AND SUBJECTIVE THRESHOLDS
Br. J. Anaesth. (1988), 61, 606-610 EFFECTS OF NITROUS OXIDE ON AUDITORY CORTICAL EVOKED POTENTIALS AND SUBJECTIVE THRESHOLDS H. G. HOUSTON, R. J. McCLELLAND AND P. B. C. FENWICK General anaesthetics are
More informationCOMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR
Br.J. Anaesth. (1977), 49, 75 COMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR D. G. LITTLEWOOD, D. B. SCOTT, J. WILSON AND B. G. COVINO SUMMARY Various
More informationNEUROMUSCULAR BLOCKING AGENTS
NEUROMUSCULAR BLOCKING AGENTS Edward JN Ishac, Ph.D. Associate Professor, Pharmacology and Toxicology Smith 742, 828-2127, Email: eishac@vcu.edu Learning Objectives: 1. Understand the physiology of the
More informationComparison between the Clinical Assessment, Peripheral Nerve Stimulation (PNS), and Acceleromyography (AMG) to Reverse Neuromuscular Blockade
PERIPHERAL THE IRAQI POSTGRADUATE NERVE STIMULATION MEDICAL JOURNAL Comparison between the Clinical Assessment, Peripheral Nerve Stimulation (PNS), and Acceleromyography (AMG) to Reverse Neuromuscular
More informationSINGLE BREATH INDUCTION OF ANAESTHESIA WITH ISOFLURANE
Br. J. Anaesth. (987), 59, 24-28 SINGLE BREATH INDUCTION OF ANAESTHESIA WITH ISOFLURANE J. M. LAMBERTY AND I. H. WILSON Two studies have demonstrated that the induction of anaesthesia using a single breath
More informationInfluence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve during thyroid surgery
British Journal of Anaesthesia 94 (5): 596 600 (2005) doi:10.1093/bja/aei110 Advance Access publication February 25, 2005 Influence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve
More informationAntagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia
British Journal of Anaesthesia 94 (6): 742 7 (2005) doi:10.1093/bja/aei120 Advance Access publication March 18, 2005 Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia
More informationPharmacokinetics of propofol when given by intravenous
Br. J. clin. Pharmac. (199), 3, 144-148 Pharmacokinetics of propofol when given by intravenous infusion DENIS J. MORGAN', GWEN A. CAMPBELL2,* & DAVID P. CRANKSHAW2 'Victorian College of Pharmacy, 381 Royal
More informationANAESTHESIA AND ACUTE DERMATOMYOSITIS/ POLYMYOSITIS
Br. J. Anaesth. (1988), 60, 854-858 ANAESTHESIA AND ACUTE DERMATOMYOSITIS/ POLYMYOSITIS R. GANTA, I. T. CAMPBELL AND S. M. MOSTAFA Dermatomyositis, a condition of unknown aetiology characterized by dermatitis,
More informationR. A. COOPER, V. R. MADDINENI, R. K. MIRAKHUR, J. M. K. H. WIERDA, M. BRADY AND K. T. J. FITZPATRICK. British Journal of Anaesthesia 1993; 71:
British Journal of Anaesthesia 13; 71: 222-226 TIME COURSE OF NEUROMUSCULAR EFFECTS AND PHARMACOKINETICS OF ROCURONIUM BROMIDE (ORG 426) DURING ISOFLURANE ANAESTHESIA IN PATIENTS WITH AND WITHOUT RENAL
More informationINTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION
Br.J. Anaesth. (1985), 57, 1089-1094 INTERACTION OF MIDAZOLAM WITH TWO NON-DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE RAT IN VIVO SCIATIC NERVE-TIBIALIS ANTERIOR MUSCLE PREPARATION J. J. DRIESSEN,
More informationEFFECT OF STRETCH EXERCISES ON SUXAMETHONIUM INDUCED FASCICULATIONS AND MYALGIA
Br. J. Anaesth. (1987), 59, 596-601 EFFECT OF STRETCH EXERCISES ON SUXAMETHONIUM INDUCED FASCICULATIONS AND MYALGIA D. A. MAGEE AND R. J. S. ROBINSON The speed of onset of blockade and the excellent intubating
More informationNeuromuscular Monitoring and Patient Safety:
Neuromuscular Monitoring and Patient Safety: Pulmonary Complications of Residual Block CEEA Course Tuesday, Sept 4, 2012 Târgu Mureş, Romania Sorin J. Brull, MD, FCARCSI (Hon) Editor, Patient Safety Section
More information(PP XI) Dr. Samir Matloob
DRUGS ACTING ON THE CHOLINERGIC SYSTEM AND THE NEUROMUSCULAR BLOCKING DRUGS IV (NICOTINIC ANTAGONISTS) (PP XI) Dr. Samir Matloob Dept. of Pharmacology Baghdad College of Medicine Drugs acting on the cholinergic
More informationEVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION
Original Article EVALUATION OF ATRACURIUM BESYLATE AND VECURONIUM BROMIDE IN COMBINATION TO FACILITATE RAPID TRACHEAL INTUBATION Kiran B Patel 1, Ananyaruchi S Sharma 2, Hitesh S Patel 2, Rahul D Patel
More informationQUANTITATIVE EEG AND BRAINSTEM AUDITORY EVOKED POTENTIALS: COMPARISON OF ISOFLURANE WITH HALOTHANE USING THE CEREBRAL FUNCTION ANALYSING MONITORf
British Journal of Anaesthesia 1990; 65: 306-312 QUANTITATIVE EEG AND BRAINSTEM AUDITORY EVOKED POTENTIALS: COMPARISON OF ISOFLURANE WITH HALOTHANE USING THE CEREBRAL FUNCTION ANALYSING MONITORf A. R.
More informationChapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
Chapter 18 Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Uses of Neuromuscular Blocking Facilitate intubation Surgery Agents Enhance ventilator synchrony Reduce intracranial pressure (ICP)
More informationCLINICAL ASSESSMENT OF NEUROMUSCULAR TRANSMISSION
Br. J. Anaesth. (1982), 54, 209 CLINICAL ASSESSMENT OF NEUROMUSCULAR TRANSMISSION J. VIBY-MOGENSEN Traditionally, the degree of neuromuscular blockade during and after anaesthesia is evaluated solely on
More informationComparison of integrated. between the hypothenar and facial muscle groups following atracurium and vecuronium administration
318 Comparison of integrated evoked EMG between the hypothenar and facial muscle groups following atracurium and vecuronium administration M.D. Sharpe MD, C.A. Moote MD, A.M. Lam MO, P.H. Manninen MD In
More informationOnset of action and intubating conditions after administration of rocuronium or mivacurium in children
79 Onset of action and intubating conditions after administration of rocuronium or mivacurium in children Papagiannopoulou Pinelopi, Sfyra Evaggelia, Georgiou Mary, Georgiadou Theodora, Kanakoudis Fotios
More informationA. G. HEAD-RAPSON, J. C. DEVLIN, C. J. R. PARKER AND J. M. HUNTER. Summary. British Journal of Anaesthesia 1995; 75: 31 36
British Journal of Anaesthesia 1995; 75: 31 36 Pharmacokinetics and pharmacodynamics of the three isomers of mivacurium in health, in end-stage renal failure and in patients with impaired renal function
More informationEffect of Vecuronium in different age group
Original Research Article Effect of Vecuronium in different age group Bharti Rajani 1, Hitesh Brahmbhatt 2, Hemlata Chaudhry 2, Hiren Parmar 3* 1 Associate Professor, Department of Anesthesiology, GMERS
More informationNEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK
EDITORIAL NEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK Neostigmine is the classic acetylcholinesterase antagonist, which is widely used for reversal of neuromuscular block of all nondepolarising
More informationComparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.21.383.x Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients Simone van Kralingen,
More informationPHARMACOKINETICS OF FENTANYL DURING CONSTANT RATE I.V. INFUSION FOR THE RELIEF OF PAIN AFTER SURGERY
Br. J. Anaesth. (1986), 58, 950-956 PHARMACOKINETICS OF FENTANYL DURING CONSTANT RATE I.V. INFUSION FOR THE RELIEF OF PAIN AFTER SURGERY D. J. R. DUTHIE, A. D. McLAREN AND W. S. NIMMO Acute pain after
More informationCHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A
CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory
More informationMaterials and Methods
Anesthesiology 2002; 97:616 21 2002 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Duration of Anesthesia before Muscle Relaxant Injection Influences Level of Paralysis
More informationThe dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children
246 Nishan G. Goudsouzian Mo, Jeevendra J.A. Martyn MD, Letty M.P. Liu MO, Hassan H. All MI~ The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children Cumulative
More informationEFFECT OF HALOTHANE, ENFLURANE AND ISOFLURANE ON BODY TEMPERATURE DURING AND AFTER SURGERY
Br. J. Anaesth. (1989), 6, 409-414 EFFECT OF HALOTHANE, ENFLURANE AND SOFLURANE ON BODY TEMPERATURE DURNG AND AFTER SURGERY V. RAMACHANDRA, C. MOORE, N. KAUR AND F. CARL Heat loss occurs during anaesthesia
More informationROCURONIUM BROMIDE VERSUS VECURONIUM BROMIDE: COMPARISION OF ONSET, INTUBATING CONDITION AND DURATION OF ACTION Darshna D Patel 1*, Varsha N Swadia 2
ORIGINAL ARTICLE ROCURONIUM BROMIDE VERSUS VECURONIUM BROMIDE: COMPARISION OF ONSET, INTUBATING CONDITION AND DURATION OF ACTION Darshna D Patel 1*, Varsha N Swadia 2 1 Assistant professor, 2 Professor
More informationIBUPROFEN IN THE MANAGEMENT OF POSTOPERATIVE PAIN
Br.J. Anaesth. (1986), 58, 171-175 IBUPROFEN IN THE MANAGEMENT OF POSTOPERATIVE PAIN H. OWEN, R. J. GLAVIN AND N. A. SHAW In addition to the control of symptoms associated with arthritis, non-steroidal
More informationDepartment of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Indian J Med Res 122, October 2005, pp 319-323 A randomized controlled double blind study on quick intubation regimen using vecuronium priming infusion technique with the use of patient controlled analgesia
More informationCLINICAL COMPARISON OF D-TUBOCURARINE AND PANCURONIUM: DOSAGE SCHEDULE BASED ON LEAN BODY MASS
CLINICAL COMPARISON OF D-TUBOCURARINE AND PANCURONIUM: DOSAGE SCHEDULE BASED ON LEAN BODY MASS E. NICKORICK, M.D. AND F.B. REYNOLDS, M.D. PANCURONIUM BROMIDE, a non-depolarizing neuromuscular blocking
More informationEFFECT OF PROPOFOL ON THE AUDITORY EVOKED RESPONSE AND OESOPHAGEAL CONTRACTILITY
Br. J. Anaesth. (1989), 3, 411-41 EFFECT OF PROPOFOL ON THE AUDTORY EVOKED RESPONSE AND OESOPHAGEAL CONTRACTLTY C. THORNTON, K. M. KONECZKO, A. B. KNGHT, B. KAUL, J. G. JONES, C. J. DORE AND D. C. WHTE
More informationNITROUS OXIDE-CURARE ANESTHESIA UNSUPPLEMENTED WITH CENTRAL DEPRESSANTS
Brit. J. Anasth. (1953). 25, 237 NITROUS OXIDE-CURARE ANESTHESIA UNSUPPLEMENTED WITH CENTRAL DEPRESSANTS By HENNING RUBEN The Finsen Institute, Copenhagen IN a previous communication (Ruben and Andreassen,
More information2003 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.
CLINICAL INVESTIGATIONS Anesthesiology 2003; 98:1042 8 2003 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Residual Paralysis in the PACU after a Single Intubating Dose
More informationSevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time
907 General Anesthesia Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time [Le sévoflurane et l isoflurane, mais pas le propofol, diminuent les besoins en mivacurium
More informationMonitoring Neuromuscular Blockade. Glenn S. Murphy, MD Joseph W. Szokol, MD
Monitoring Neuromuscular Blockade Glenn S. Murphy, MD Joseph W. Szokol, MD Neuromuscular-blocking agents (NMBA) have been used in clinical anesthesia for nearly 60 years. In the perioperative period, a
More informationBIS Monitoring. ASSESSMENT OF DEPTH OF ANAESTHESIA. Why measure depth of anaesthesia? or how to avoid. awareness in one easy lesson
BIS Monitoring or how to avoid www.eurosiva.org awareness in one easy lesson ASSESSMENT MONITORING ANAESTHETIC DEPTH OF DEPTH OF ANAESTHESIA Why measure depth of anaesthesia? How do the various EEG monitors
More informationZekeriyya Alanoglu. Definition of Residual Neuromuscular Block
Postoperative Residual Neuromuscular Block Zekeriyya Alanoglu Almost 60 years ago the use neuromuscular blocking agents (NMBA) was associated with significantly increased risk of perioperative (approx.
More informationEVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE
EVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE Revathy Jeevarathnam 1, Balasubramaniam Solaiappan 2 1Professor, Department of Anaesthesiology, Chengalpattu Medical
More informationPharmacokinetics. Inhalational Agents. Uptake and Distribution
Pharmacokinetics Inhalational Agents The pharmacokinetics of inhalational agents is divided into four phases Absorption Distribution (to the CNS Metabolism (minimal Excretion (minimal The ultimate goal
More informationAnesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:
Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Understand the use of neuromuscular
More informationNeuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 2, June: 17-113, 24 Neuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
More informationEFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT
British Journal of Anaesthesia 199; 64: 199-26 EFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT L. GRAMSTAD AND E. S. HYSING SUMMARY We have determined
More informationJournal of Anesthesia & Clinical
Journal of Anesthesia & Clinical Research ISSN: 2155-6148 Journal of Anesthesia & Clinical Research Balasubramanian and Menaha, J Anesth Clin Res 2017, 8:12 DOI: 10.4172/2155-6148.1000791 Research Article
More informationEffect of low-dose enflurane on the ventilatory response to hypoxia in humans
British Journal of Anaesthesia 1994; 72: 59-514 CLINICAL INVESTIGATIONS Effect of low-dose enflurane on the ventilatory response to hypoxia in humans B. NAGYOVA, K. L. DORRINGTON AND P. A. ROBBINS SUMMARY
More informationPLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS
Br. J. Anaesth. (988), 6, 64-68 PLASMA FENTANYL CONCENTRATIONS DURING TRANSDERMAL DELIVERY OF FENTANYL TO SURGICAL PATIENTS D. J. R. DUTHIE, D. J. ROWBOTHAM, R. WYLD, P. D. HENDERSON AND W. S. NIMMO Pain
More information13.01 INHALATIONAL & IV ANAESTHETICS
13 ANAESTHETICS 13.01 INHALATIONAL & IV ANAESTHETICS Halothane (Fluothane) 250ml Isoflurane (Forane) 250ml *Ketamine (as HCl) Inj 50mg/ml, 10ml (Ketalar) *Nitrous Oxide Inhalation Gas [Cylinder neck: colour
More informationCONCENTRATIONS OF DIETHYL ETHER IN THE BLOOD OF INTUBATED AND NON-INTUBATED PATIENTS
Brit. J. Anaesth. (1954), 26, 111. CONCENTRATIONS OF DIETHYL ETHER IN THE BLOOD OF INTUBATED AND NON-INTUBATED PATIENTS BY A. MACKENZIE, E. A. PASK AND J. G. ROBSON Medical School, King's College, and
More informationInhalation of Isoflurane or Sevoflu. Citation Acta medica Nagasakiensia. 1996, 41
NAOSITE: Nagasaki University's Ac Title Author(s) Hemodynamic and Catecholamine Respo Inhalation of Isoflurane or Sevoflu Tomiyasu, Shiro; Hara, Tetsuya; Mor Sumikawa, Koji Citation Acta medica Nagasakiensia.
More informationFrom World Federation of Societies of Anaesthesiologists Comments on review of WHO / EML Anaesthetic drugs and muscle relaxants Dr Michael Dobson
From World Federation of Societies of Anaesthesiologists Comments on review of WHO / EML Anaesthetic drugs and muscle relaxants Dr Michael Dobson Comments on ISDB single medicines review Anaesthetic Ether
More informationThe Latest Approaches to Reversal of Neuromuscular Blocking Agents
The Latest Approaches to Reversal of Neuromuscular Blocking Agents Janay Bailey, Pharm.D. Anesthesiology 2017; 126:173-90 Objectives Pharmacists Determine optimal paralytic choices in knowing if reversal
More informationAccumulation of foreign gases during closed-system anaesthesia
British Journal of Anaesthesia 1996; 76: 668 672 Accumulation of foreign gases during closed-system anaesthesia L. VERSICHELEN, G. ROLLY AND H. VERMEULEN Summary In a previous study, accumulation of methane
More informationPHARMACOKINETICS OF COMPETITIVE MUSCLE RELAXANTS
f. J. Anaesth. (1982), 54, 161 PHARMACOKINETICS OF COMPETITIVE MUSCLE RELAXANTS Pharmacokinetics refers to the rates of distribution, metabolism and excretion of a drug or its metabolites, or both. Pharmacodynamics,
More informationThe cholinesterase inhibitors, neostigmine and edrophonium,
Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Glycopyrrolate and Atropine Ozlem Sacan, MD Paul F. White, MD, PhD Burcu Tufanogullari, MD Kevin Klein, MD BACKGROUND: is a modified
More informationS. SAKURABA (*), R. SERITA (**), S. KOSUGI**, L. I. ERIKSSON (***), S. G. E. LINDAHL (***) and J. TAKEDA (*)
(Acta Anaesth. Belg., 2006, 57, 253-257) Pretreatment with magnesium sulphate is associated with less succinylcholine-induced fasciculation and subsequent tracheal intubation-induced hemodynamic changes
More informationMUSCLE relaxants are used to provide better operating conditions for
CLEVELAND CLINIC QUARTERLY Copyright 1970 by The Cleveland Clinic Foundation Volume 37, July 1970 Printed in U.S.A. Pancuronium bromide A new non-depolarizing muscle relaxant Preliminary in fifty patients
More informationComparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)
ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) K Bhati, V Parmar Citation K Bhati,
More informationEffect of Magnesium Sulphate on the Speed of Onset and Duration of Neuromuscular Block Produced by Rocuronium Bromide
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 2 Ver. VI (February. 2017), PP 54-58 www.iosrjournals.org Effect of Magnesium Sulphate on the
More informationChapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise
Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise 1. Read chapter 2. Review objectives (p.305) 3. Review key terms and definitions (p.305) Add: Cholinesterase inhibitor Vagal
More informationInhalational Anesthesia. Munir Gharaibeh, MD, PhD, MHPE School of Medicine The University of Jordan February, 2018
Inhalational Anesthesia School of Medicine The University of Jordan February, 2018 mgharaib@ju.edu.jo Inhalational Anesthesia n Gases or volatile liquids n Administration and Elimination is by the lungs
More informationTHE TOXICITY OF XYLOCAINE
THE TOXICITY OF XYLOCAINE By A. R. HUNTER T HE local anaesthetic drug was discovered some years ago by Lofgren (1948), and has been used quite extensively in clinical anaesthesia in Sweden. It has proved
More informationClinical Evaluation of Isoflurane DEMOGRAPHY OF PATIENT POPULATION JAMES B. FORREST
Clinical Evaluation of Isoflurane DEMOGRAPHY OF PATIENT POPULATION JAMES B. FORREST SINCE THE AIM of the clinical evaluation of isoflurane was to assess its efficacy and safety in a wide spectrum of clinical
More informationComparison Of Plasma Cholinesterase Levels And The Duration Of Suxamethonium Apnoea In Nigerian Adult And Paediatric Patients
ISPUB.COM The Internet Journal of Anesthesiology Volume 30 Number 2 Comparison Of Plasma Cholinesterase Levels And The Duration Of Suxamethonium Apnoea In Nigerian Adult And Paediatric Patients A OO, D
More informationBritish Journal of Anaesthesia 96 (6): (2006) doi: /bja/ael092 Advance Access publication April 13, 2006 Emergence and recovery in childr
British Journal of Anaesthesia 96 (6): 779 85 (6) doi:.93/bja/ael92 Advance Access publication April 13, 6 Emergence and recovery in children after desflurane and isoflurane anaesthesia: effect of anaesthetic
More informationDIFFERENTIAL NERVE BLOCKADE: ESTERS V. AMIDES AND THE INFLUENCE OF pk a
Br. J. Anaesth. (198), 59, 39-384 DIFFERENTIAL NERVE BLOCKADE: ESTERS V. AMIDES AND THE INFLUENCE OF pk a J. A. W. WILDSMITH, A. J. GISSEN, B. TAKMAN AND B. G. COVINO All the clinically useful local anaesthetic
More informationNeuromuscular Junction
Muscle Relaxants Neuromuscular Junction Cholinergic antagonists Neuromuscular-blocking agents (mostly nicotinic antagonists): interfere with transmission of efferent impulses to skeletal muscles. These
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationPREMEDICATION WITH SLOW RELEASE MORPHINE (MST) AND ADJUVANTS
Br. J. Anaesth. (1988), 60, 825-830 PREMEDICATION WITH SLOW RELEASE MORPHINE (MST) AND ADJUVANTS K. H. SIMPSON, M. J. DEARDEN, F. R. ELLIS AND T. M. JACK Opioids are used widely for premedication, as they
More informationBETA-ADRENOCEPTOR BLOCKADE, ALPHA-STIMULATION AND CHANGES IN PLASMA POTASSIUM CONCENTRATION AFTER SUXAMETHONIUM ADMINISTRATION IN DOGSf
Br.J. Anaesth. (987), 59, 6-66 BETA-ADRENOCEPTOR BLOCKADE, ALPHA-STIMULATION AND CHANGES IN PLASMA POTASSIUM CONCENTRATION AFTER SUXAMETHONIUM ADMINISTRATION IN DOGSf D. R. GOLDHILL, J. A. J. MARTYN AND
More informationI. P. LATTO, M. J. MOLLOY AND M. ROSEN
Brit. J. Anaesth. (13), 4,2 ARTERIAL CONCENTRATIONS OF NITROUS OXIDE DURING INTERMnTENT PATIENT-CONTROLLED INHALATION OF 0% NITROUS OXIDE IN OXYGEN (ENTONOX) DURING THE FIRST STAGE OF LABOUR I. P. LATTO,
More informationComparison of Intubating Conditions of Succinylcholine and Rocuronium
Comparison of Intubating Conditions of Succinylcholine and Rocuronium 1 Dr. Vaishali Kotambkar, 2 Dr. Sunil Tuljapure Abstract: The aim of study on neuromuscular drugs was to have nondepolarising muscle
More informationEvaluation of Postoperative Complications Occurring in Patients after Desflurane or Sevoflurane in Outpatient Anaesthesia: A Comparative Study
Original article Evaluation of Postoperative Complications Occurring in Patients after Desflurane or Sevoflurane in Outpatient Anaesthesia: A Comparative Study Shishir Ramachandra Sonkusale 1, RajulSubhash
More informationBronchial mucus transport velocity in patients receiving desflurane and fentanyl vs. sevoflurane and fentanyl
European Journal of Anaesthesiology 2008; 25: 752 755 r 2008 Copyright European Society of Anaesthesiology doi:10.1017/s0265021508004304 Original Article Bronchial mucus transport velocity in patients
More information